Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.37 |
| ▸ | RAB9A | P51151 | 5/20 | 0.37 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | GFER | P55789 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15357901 | 0.90 | RAB9A (0.41) | MAPTRAB9ANPC1KMT2APSMD14 | |
| SCHEMBL20999602 | 0.90 | MAPT (0.40) | MAPTRAB9ANPC1KMT2APSMD14 | |
| SCHEMBL18556273 | 0.90 | MAPT (0.40) | MAPTRAB9ANPC1KMT2APSMD14 | |
| SCHEMBL2602717 | 0.85 | MMP14 (0.47) | MAPTRAB9ANPC1KMT2ATHRB | |
| SCHEMBL6932967 | 0.85 | MMP14 (0.47) | MAPTRAB9ANPC1KMT2ATHRB | |
| SCHEMBL3317586 | 0.84 | MLYCD (0.41) | MAPTRAB9ANPC1KMT2APSMD14 | |
| SCHEMBL13378764 | 0.84 | MAPT (0.44) | MAPTRAB9ANPC1KMT2ATSHR | |
| SCHEMBL14505212 | 0.84 | MAPT (0.39) | MAPTRAB9ANPC1KMT2APSMD14 | |
| SCHEMBL2982149 | 0.84 | MAPT (0.44) | MAPTRAB9ANPC1KMT2ATSHR | |
| SCHEMBL2609226 | 0.83 | KDM4E (0.38) | MAPTRAB9ANPC1KMT2APSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168764-B2 | Polyfunctional compound, optical recording material, optical recording medium, optical recording/reproducing apparatus, optical waveguide material, and photo-alignment film material | NITTO DENKO CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8158737-B2 | Method for production of polyfunctional compound | NITTO DENKO CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20110098454-A1 | METHOD FOR PRODUCTION OF POLYFUNCTIONAL COMPOUND | NITTO DENKO CORPORATION (JP) | 2011-04-28 | — | — | US | disclosed |
| US-7884167-B2 | conducting a Michael addition of a compound (A) having a hydrogen atom of pKa less than or equal to 15 to a (meth)acrylate or a (meth)acrylamide (B), in which at least one of the compounds (A) and (B) has a photoisomerization group; optical recording material, optical waveguide material | NITTO DENKO CORPORATION (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20090182107-A1 | METHOD FOR PRODUCTION OF POLYFUNCTIONAL COMPOUND | NITTO DENKO CORPORATION (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098454-A1 | METHOD FOR PRODUCTION OF POLYFUNCTIONAL COMPOUND | ADCY10, ADCY5, ADCY1 | MAPT 1641/4885RAB9A 1805/4885NPC1 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.